CIDRAP newsletters options
About 38% of patients experiencing stillbirth received a COVID-19 vaccine in pregnancy, compared with 39% of those with live births.
A study in Texas finds a higher prevalence of antimicrobial-resistant organisms in areas with high levels of economic deprivation.
New CDC data show upticks in early COVID-19 indicators, but severity indicators remain unchanged from the previous week.
Minnesota and Iowa report infected dairy herds.
Administering antibiotics more than 5.5 hours after emergency department arrival was associated with increased odds of 3- and 30-day mortality.
Fifty-four people have been hospitalized, with no deaths reported.
The findings don't change the need for continued disease surveillance and research, experts say.
Though the vote was unanimous, discussions were complicated by the diversity of JN.1 viruses.
The report "offers a comprehensive review of the evidence base for how Long COVID may impact a patient's ability to engage in normal activities."
The agency hopes that preventive use of doxycycline after sex could help prevent bacterial STIs in men who have sex with men and transgender women.
The infection is caused by Trichophyton mentagrophytes type VII, a fungus that may spread via sexual contact.
Data show US TB programs have made strides in identifying patients with TB and latent TB infection and in ensuring they complete treatment in a timely manner.
Cross-reactivity among orthoflaviviruses should be considered when testing vaccines against the diseases they cause, the researchers say.
Facilities with PPE shortages had an additional 14.81 cases per 100 residents.
The "duckbill" N95 stopped 98% of the virus that causes COVID-19, the authors say.
In other updates, the USDA also reported more H5N1 detections in wild birds and mammals.
Though data reflect ongoing low-level transmission in multiple regions, the WHO said reduced reporting may underestimate illness levels.
In 2020, 1,033,122 excess deaths were recorded, and that number rose in 2021 to 1,256, 942.
The false belief is undermining efforts to address the country's rising measles cases through vaccination.
Company officials say the lab will expand an existing R&D facility for San Diego–based Qpex Biopharma, which was acquired by Shionogi in 2023.